F. Gao, Kenneth I Zheng, Xiaobo Wang, Huadong Yan, Qing-Feng Sun, Ke-Hua Pan, Ting-Yao Wang, Yong-Ping Chen, J. George, M. Zheng
Journal of gastroenterology and hepatology, 2020
Coronavirus disease 2019 (COVID‐19) has attracted increasing worldwide attention. While diabetes is known to aggravate COVID‐19 severity, it is not known whether nondiabetic patients with metabolic dysfunction are also more prone to more severe disease. The association of metabolic associated fatty liver disease (MAFLD) with COVID‐19 severity in nondiabetic patients was investigated here.
Cited by 40 publications.
Field of study: Medicine